Filing Details
- Accession Number:
- 0001415889-19-000015
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2019-01-02 18:44:36
- Reporting Period:
- 2018-12-28
- Accepted Time:
- 2019-01-02 18:44:36
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1604191 | Azurrx Biopharma Inc. | AZRX | Pharmaceutical Preparations (2834) | 000000000 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1658369 | Maged Shenouda | Suite 304 Brooklyn NY 11226 | Chief Financial Officer | No | No | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2018-12-28 | 20,000 | $1.31 | 62,500 | No | 4 | P | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | P | Direct |
Billionaire Hedge Funds
